Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-01 Hall Jesse Wayne Chief Medical Officer Exercise or conversion +36,375 36,375
2026-05-01 Hall Jesse Wayne Chief Medical Officer Shares withheld for taxes −9,330 $4.41 $41K 27,045
2026-05-01 Hall Jesse Wayne Chief Medical Officer Exercise or conversion · Restricted Stock Units −36,375 109,125
2026-02-02 Hall Jesse Wayne Chief Medical Officer Grant or award · Restricted Stock Units +98,100 98,100
2026-02-02 Hall Jesse Wayne Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +343,300 343,300
2025-05-01 Hall Jesse Wayne Chief Medical Officer Grant or award · Restricted Stock Units +145,500 145,500
2025-05-01 Hall Jesse Wayne Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +510,000 510,000

Page 1 of 1 · 7 trades